Cargando…
Ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) is a potential tumour suppressor in prostate cancer and is frequently silenced by promoter methylation
BACKGROUND: We have previously reported significant downregulation of ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) in prostate cancer (PCa) compared to the surrounding benign tissue. UCHL1 plays an important role in ubiquitin system and different cellular processes such as cell proliferation and...
Autores principales: | Ummanni, Ramesh, Jost, Edgar, Braig, Melanie, Lohmann, Frithjof, Mundt, Frederike, Barett, Christine, Schlomm, Thorsten, Sauter, Guido, Senff, Tina, Bokemeyer, Carsten, Sültmann, Holger, Meyer-Schwesinger, Catherine, Brümmendorf, Tim H, Balabanov, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3212821/ https://www.ncbi.nlm.nih.gov/pubmed/21999842 http://dx.doi.org/10.1186/1476-4598-10-129 |
Ejemplares similares
-
Identification of Clinically Relevant Protein Targets in Prostate Cancer with 2D-DIGE Coupled Mass Spectrometry and Systems Biology Network Platform
por: Ummanni, Ramesh, et al.
Publicado: (2011) -
Overexpression of ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) in boys with cryptorchidism
por: Toliczenko-Bernatowicz, Dorota, et al.
Publicado: (2018) -
Abcg2 Overexpression Represents a Novel Mechanism for Acquired Resistance to the Multi-Kinase Inhibitor Danusertib in BCR-ABL-Positive Cells In Vitro
por: Balabanov, Stefan, et al.
Publicado: (2011) -
Pivotal Role of Ubiquitin Carboxyl-Terminal Hydrolase L1 (UCHL1) in Uterine Leiomyoma
por: Suzuki, Tomoo, et al.
Publicado: (2023) -
Combination of a Proteomics Approach and Reengineering of Meso Scale Network Models for Prediction of Mode-of-Action for Tyrosine Kinase Inhibitors
por: Balabanov, Stefan, et al.
Publicado: (2013)